TMCnet

Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
IEEE

Amplitude-Phase-Sphere Block Modulation and Demodulation for Resisting Phase Noise in Millimeter-Wave Single-Carrier Wireless Communications

Abstract: Phase noise (PN) significantly degrades the performance of millimeter-wave (mmWave) wireless communication systems. To mitigate this challenge, we propose the amplitude-phase-sphere block ...
The Pharma Letter

Saturnus Bio

A Versant Ventures-founded biotech using targeted gene modulation to build a foundational portfolio in rare monogenic ...
IEEE

Hybrid Modulation-Based Discrete Extended-Phase-Shift Control for Dual-Active-Bridge DC-DC Converter

Abstract: Aimed at the modulation and control of dual active bridge (DAB) dc–dc converter, a hybrid modulation method and the corresponding discrete control strategy are proposed to achieve fast and ...